Sudeep Pharma IPO gets big thumbs up from retail investors

Business Nov 24, 2025

Sudeep Pharma's IPO is making waves, especially with everyday investors—it's already 2.27 times subscribed just by day two.
Shares are priced between ₹563-593, and the company is looking to raise ₹895 crore before bidding closes on November 25.

Who's investing—and why?

Retail buyers are leading the charge, snapping up over double their reserved shares at the cut-off price.
Non-institutional investors, including high-net-worth folks, have oversubscribed their portion too—some by more than five times.
Sudeep Pharma's popularity comes from its strong presence in pharma and food ingredients, plus its status as India's top maker of food-grade iron phosphate.
QIBs (big institutional players) are taking it slow for now but often jump in closer to the deadline.